| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Allie K Adams, PHD |
Training Program in Cancer Therapeutics |
National Institutes of Health (University of Cincinnati) |
T32 CA117846 |
9/14/2015 - 9/13/2016 |
$42,840 |
| Mohammad Azam, PHD |
Improved Therapeutic Approaches for Hematological Disorder Treated with Tyrosine |
National Institutes of Health |
R01 CA155091 |
4/1/2016 - 3/31/2017 |
$317,475 |
| Gang Huang, PHD |
Role of the Hypoxia-Inducible Factor-1alpha in Myelodysplastic Syndromes |
National Institutes of Health |
R01 DK105014 |
3/1/2015 - 2/29/2020 |
$351,000 |
| Gang Huang, PHD |
A Novel Epigenetic Circuit in Acute Leukemia |
National Institutes of Health |
R21 CA187276 |
7/9/2014 - 6/30/2017 |
$203,580 |
| Purnima K Wagh, PHD |
p130 and Pim-1 as Prognostic Biomarkers and Therapeutic |
National Institutes of Health |
F32 CA89685 |
9/1/2014 - 8/31/2016 |
$57,613 |
| Kathryn Ann Wikenheiser-Brokamp, MD-PHD |
Mechanisms Underlying DICER1 Suppression of Pleuropulmony Blastoma |
St. Baldrick's Foundation |
Award ID 209927 |
7/1/2011 - 6/30/2016 |
$142,697 |
| Kathryn Ann Wikenheiser-Brokamp, MD-PHD |
Hypoxia Signaling and Spontaneous Pulmonary Fibrosis in a Novel Mouse Model |
National Institutes of Health (University of South Florida) |
R21 AG047473 |
1/15/2015 - 12/31/2016 |
$71,916 |
| Total Annual Grant Award Dollars |
$1,187,121 |
